MUMBAI (Reuters) - A U.S. federal judge has denied Indian generic drugmaker Ranbaxy Laboratories Ltd's bid to reinstate approvals granted to it to launch the first copies of the heartburn drug Nexium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback